AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Kimberly-Clark agreed to acquire Kenvue in a $48.7 billion deal, valuing the consumer health company at a 50% premium. Kenvue shareholders will receive $3.50 per share in cash and KMB stock, unlocking $2.1 billion in synergies. Despite a 15% surge, Kenvue stock is down over 30% YTD. Analysts and investor Jim Cramer see the deal as positive for KVUE shares, citing operational upside and long-term potential.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet